Thus, checkpoint inhibitors that could prevent CD8+ T cells from being inactivated have almost no effect on PDAC, as the CD8+ T cells cannot even infiltrate efficiently the stroma and reach the tumor cells. Here, CD8A is linked to neoplasm.